NASDAQ:IPHA
Innate Pharma S.A.
- Stock
locale
Francemarket
STOCKSindustry
Biotechnologywebsite
www.innate-pharma.comipo date
Nov 01, 2006
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus